Pfizer to Change Chantix Label to Show Cardiovascular Risks
The FDA is asking Pfizer to update the label of its popular quit-smoking drug Chantix to include additional safety risks, including heart attack, for patients with cardiovascular disease.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.